Drugmakers see innovation justifying further price rises

Reuters | By Deena Beasley

SAN FRANCISCO, Jan 17 (Reuters) – As U.S. consumers are asked to shoulder more prescription drug costs, drugmakers say prices for brand-name medicines will keep rising, mainly because use of their products reduces other healthcare costs.